Psychotic Disorders and their Treatment - Poggio...
Transcript of Psychotic Disorders and their Treatment - Poggio...
![Page 1: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/1.jpg)
Psychotic Disordersand their Treatment
Bruce M. Cohen, M.D., Ph.D.
Director, Stanley Research Center, McLean HospitalProfessor of Psychiatry, Harvard Medical School
MIT ‘69
![Page 2: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/2.jpg)
Psychotic disorders are characterized bysubstantial abnormalities of thought,
perception, mood and behavior:
• Delusions (odd and erroneous beliefs)
• Hallucinations (False sensory percepts)
• Disorganized/illogical thinking and speech
• Odd, inappropriate or disorganized behavior
• Inappropriate or extreme mood and affect
![Page 3: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/3.jpg)
While there are many causes of psychosis,most of our patients are classified as having
either:
schizophrenia, typified by a chronic course andmore complex delusions and hallucinations
orbipolar disorder, typified by a recurrent
course and extremes of mood.
![Page 4: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/4.jpg)
However, it may be incorrect to think ofbipolar disorder and schizophrenia as
either distinct or homogeneous disorders.
Many factors may interact to producea range of conditions with various
features of the syndromes ofbipolar disorder and schizophrenia.
![Page 5: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/5.jpg)
Genetics
The inheritance of risk for psychotic disordersappears best to fit a model including multiple,interacting genes.
We are collaborating with the Broad Instituteto identify such genes, but at present nocommon risk genes are well documented.
![Page 6: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/6.jpg)
Subtle changes in the brain, especiallyin areas associated with complex
thinking and emotion, can be seen inbipolar disorder and schizophrenia.
Brain Imaging
![Page 7: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/7.jpg)
Bipolar MajorSchizophrenia Disorder Depression
MRI ↑ VBR ↓ Cerebellum ↓ Hippocampus
MRS ↓ NAA ↑ Lac, Glx ↓ β-NTP(Temporal Lobe) (Gray Matter) (Basal Ganglia)
fMR ↓ PFC ↑ Amygdala ↓ Anterior Cingulate
Examples of MR Findings in Schizophrenia,Bipolar Disorder and Major Depression
![Page 8: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/8.jpg)
Activity in the Right Medial Dorsal Thalamusduring a Verbal Fluency Task in HealthyControls and Patients with Schizophrenia
0.985
0.995
1.005
1.015
1.025
3 21 39 57 75 93 111 129 147Time (sec)
Mea
n Si
gnal
Inte
nsity
Controls
0.985
0.995
1.005
1.015
1.025
3 21 39 57 75 93 111 129 147Time (sec)
Mea
n Si
gnal
Inte
nsity
Patients
Cohen and Yurgelun-Todd
![Page 9: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/9.jpg)
Thalamus Placebo Risperidone
Cerebral Blood Volume Changes in the Thalamic RegionAfter Risperidone Treatment
Cohen and Yurgelun-Todd
![Page 10: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/10.jpg)
Currently available antipsychoticand mood stabilizing medications are
effective but work slowly,produce many side effects and
often achieve only partial symptom relief.
Treatment of Psychosis
![Page 11: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/11.jpg)
The Stanley Research Center at McLeanHospital supports a multidisciplinary teamof basic and clinical scientists devoted todiscovering new treatments for bipolardisorder, schizophrenia and related illnesses.Techniques and discoveries arise fromclinical, laboratory and brain imagingcomponents.
General Overview of Componentsof the McLean Stanley Center
![Page 12: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/12.jpg)
• Medication and other treatment trialsprovide an opportunity to study subjectswhen they are more and less symptomatic
• The effects of medication can clarify themechanism by which the brain processesinformation in health and illness
Why are treatment studies relevant tostudies of cognition and brain functioning?
![Page 13: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/13.jpg)
Kappa agentsLow Field Magnetic Stimulation (LFMS)Trace amine modulatorsNeuroregenerative agentsBone marrow derived stem cellsStress reducing agents to prevent relapse
Stanley Research Center at McLeanMajor Preclinical Projects
![Page 14: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/14.jpg)
Kappa agonists in mania SecretinD-SerineOmega 3 fatty acids plus cytidineTaurine in maniaSAMe for bipolar depressionLow field magnetic stimulationMR Biofeedback
Stanley Research Center at McLeanCurrent Clinical Trials
![Page 15: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/15.jpg)
Research by McLean investigatorssuggests that kappa receptor agonists,
antagonists and partial agonistsmay have antimanic, antidepressant
and mood stabilizing effects.
One Example of our Researchon New Treatments
![Page 16: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/16.jpg)
Increasing CREBReduces the Effects ofAntidepressants in Rats
Blocking kappa receptorsmimics the effects ofantidepressants in rats
CREB
P
P
alteredgeneexpression
dynorphin
Kappareceptor
CREB
Carlezon et al
![Page 17: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/17.jpg)
Dynorphin may also be important inmediating the effects of
antipsychotic/antimanic drugs.
![Page 18: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/18.jpg)
GFAP Dynorphin VAChT
Nucleus Accumbens Clozapine Treated Rat
Separate red and green staining indicates that cells responding to antipsychoticdrugs are not glia (GFAP) or cholinergic (VAChT).
Combined red and green staining to produce yellow indicates that activatedcells are dynorphinergic neurons.
Ma et al., 2003
![Page 19: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/19.jpg)
• Unlike current medications, agentsacting at kappa receptors may haverapid effects on mania and depression
• No currently available drugs are specifickappa receptor modulators
• We are synthesizing kappa specificagents and testing available drugs in themeantime
![Page 20: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/20.jpg)
(+/-) Pentazocine Hydrochloride
CH3
C CH3
H
NCH2CH C(CH3)2
H
HO
Action at Opiate Receptors
kappa (κ) mu (µ) delta (δ) sigma (σ)
nearly full mostly weak partial agonist antagonist agonist agonist
![Page 21: Psychotic Disorders and their Treatment - Poggio Labcbcl.mit.edu/seminars-workshops/workshops/cohen-slides.pdf · Psychotic Disorders and their Treatment Bruce M. Cohen, M.D., ...](https://reader031.fdocuments.us/reader031/viewer/2022022020/5b9e904609d3f2d7748cb828/html5/thumbnails/21.jpg)
Pentazocine Induced Change inAcute Mania or Sedation Symptom Score
0
5
10
15
Baseline(Pentazocine)
1 Hour 2 Hour(Pentazocine)
3 Hours 4 Hours 5 Hours
Less
M
ore
20
25
30
35 SedationMania
Baseline
Sco
re
in 10 subjects